Dr Kenneth Micklethwaite

A/Prof Micklethwaite is a physician scientist working in the fields of bone marrow transplant and cell and gene therapy. He is the current Medical Director of the Blood Transplant and Cell Therapies Laboratory and a chimeric antigen receptor (CAR) T-cell Clinician at Westmead Hospital.

His research interests are in developing new cell and gene therapies, he has been an Investigator on multiple cell therapy trials for treatment of infection and blood cancers including first in-man CAR T-cell trials treating leukaemia and lymphoma. He is the recipient of multiple competitive grants from the Australian National Health and Medical Research Council and other funding bodies. He has been a member and chair of the Australian Therapeutic Goods Administration Advisory Committee on Biologicals for the last 10 years and has served as co-chair of the International Society for Cell and Gene Therapy Immuno-Gene Therapy Committee. He is a clinical associate professor at the University of Sydney, supervising and teaching multiple doctoral and medical students.

‍